Brainstorm Cell Therapeutics CEO Chaim Lebovits' 2023 pay rises 1% to $1.1M
Brainstorm Cell Therapeutics reports 2023 executive compensation
By ExecPay News
Published: August 16, 2024
Brainstorm Cell Therapeutics reported fiscal year 2023 executive compensation information on August 16, 2024.
In 2023, five executives at Brainstorm Cell Therapeutics received on average a compensation package of $673K, a 27% decrease compared to previous year.
Average pay of disclosed executives at Brainstorm Cell Therapeutics
Chaim Lebovits, Chief Executive Officer, received $1.1M in total, which increased by 1% compared to 2022. 39% of Lebovits' compensation, or $442K, was in salary. Lebovits also received $250K in bonus, $250K in stock awards, as well as $187K in other compensation.
Stacy Lindborg, Chief Executive Officer, received a compensation package of $1M, which increased by 18% compared to previous year. 47% of the compensation package, or $475K, was in salary.
Ralph Kern, Chief Medical Officer, earned $833K in 2023, a 3% increase compared to previous year.
Uri Yablonka, Secretary, received $247K in 2023.
Alla Patlis, Chief Financial Officer, earned $147K in 2023.
Related executives
Chaim Lebovits
Brainstorm Cell Therapeutics
Chief Executive Officer
Ralph Kern
Brainstorm Cell Therapeutics
Chief Medical Officer
Stacy Lindborg
Brainstorm Cell Therapeutics
Chief Executive Officer
Uri Yablonka
Brainstorm Cell Therapeutics
Secretary
Alla Patlis
Brainstorm Cell Therapeutics
Chief Financial Officer
You may also like
Source: SEC filing on August 16, 2024.